Bone Mineral Density and Osteoarthritis Interactions

Bone mineral density (BMD) and osteoarthritis (OA) represent two intimately linked facets of skeletal health. While BMD quantifies the structural integrity of bone through measures of mineral content, OA epitomises the progressive degeneration of joint cartilage and its supporting structures. Traditionally considered opposing conditions, an accumulating evidence base elucidates a more nuanced interplay. Elevated BMD has been associated with hypertrophic OA phenotypes characterised by prominent osteophyte formation and subchondral bone sclerosis, suggesting an overactive bone-forming response. Conversely, reduced BMD may exacerbate subchondral microarchitectural deterioration, thereby compromising the mechanical and biochemical milieu that sustains healthy articular cartilage. Investigations have implicated subchondral trabecular architecture, osteoclast activity, and signalling pathways such as RANK/RANKL/OPG in mediating the crosstalk between bone and joint tissues. This bidirectional relationship carries substantial global significance given the ageing population and the concomitant rise in both osteoporosis and OA. Understanding the mechanisms underlying BMD–OA interactions not only refines risk stratification but also informs the development of therapeutic strategies targeting bone remodelling to halt or reverse joint degeneration.

Research from Nature Portfolio

In a recent animal model study, the impact of established osteoporosis on knee OA pathology was dissected through ovariectomy-induced bone loss followed by meniscal injury in rats. Coexisting osteoporosis and OA accelerated subchondral trabecular porosity and increased osteoclast density within weight-bearing regions compared with OA alone. The integrity of the calcified cartilage tidemark was also compromised to a greater degree, underscoring a potentiated bone–cartilage interface disruption. These findings highlight osteoclast-driven subchondral remodelling as a pivotal amplifier of OA severity in osteoporotic contexts.

Bone Mineral Density and Osteoarthritis Interactions publication trend

The graph below shows the total number of articles in bone mineral density and osteoarthritis interactions across all publications each year (not limited to Nature Index journals).

Technical terms

Bone mineral density (BMD): A quantitative measure of bone mineral content per unit area, reflecting bone strength.

Osteoarthritis (OA): A degenerative joint disorder characterised by cartilage breakdown, subchondral bone remodelling, and osteophyte formation.

Subchondral bone: The layer of bone directly beneath the cartilage of a joint, critical for load distribution and joint integrity.

Osteoclast: A specialised bone cell responsible for resorption of bone matrix during remodelling.

Osteophyte: A bony outgrowth at joint margins, commonly observed in osteoarthritis.

Mendelian randomisation: A genetic epidemiological method that uses inherited genetic variants as proxies for modifiable exposures to infer causality.

Dual-energy X-ray absorptiometry (DXA): An imaging technique used to assess BMD by measuring the differential attenuation of X-rays of two energy levels.

References

1. The causal association between bone mineral density and risk of osteoarthritis: A Mendelian randomization study. Frontiers in Endocrinology (2023).
2. Osteoporosis and osteoarthritis: a bi-directional Mendelian randomization study. Arthritis Research & Therapy (2023).
3. The effect of postmenopausal osteoporosis on subchondral bone pathology in a rat model of knee osteoarthritis. Scientific Reports (2023).
4. Associations between systemic bone mineral density and early knee cartilage changes in middle-aged adults without clinical knee disease: a prospective cohort study. Arthritis Research & Therapy (2017).
5. Osteophytes, Enthesophytes, and High Bone Mass: A Bone‐Forming Triad With Potential Relevance in Osteoarthritis. Arthritis & Rheumatology (2014).